Mazzone v. Secretary of Health and Human Services
CourtUnited States Court of Federal Claims
Date FiledJuly 22, 2026
Docket22-1891V
JudgeChristian J. Moran
StatusPublished
📰 News Coverage: Read the LAWS.com news report on this case
Full Opinion
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
*************************
JANMARIE MAZZONE, * No. 22-1891V
*
Petitioner, *
* Special Master Christian J. Moran
v. *
* Filed: June 25, 2026
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*************************
Jessi Carin Huff, Maglio Christopher & Toale, Seattle, WA, for petitioner;
James Vincent Lopez, United States Dep’t of Justice, Washington, DC, for respondent.
PUBLISHED DECISION AWARDING ATTORNEYS’ FEES AND COSTS 1
Janmarie Mazzone alleged that an influenza vaccine she received on November 30, 2021,
caused her to develop Guillain-Barré syndrome (“GBS”). After filing medical records and
receiving the Secretary’s assessment that she was not entitled to compensation, Ms. Mazzone
dismissed her case voluntarily. Entitlement Decision, issued July 22, 2024, 2024 WL 3825581.
Ms. Mazzone is now seeking an award of attorneys’ fees and costs. The Secretary
opposes on the ground that Ms. Mazzone has not established a prerequisite for a discretionary
award of attorneys’ fees, namely reasonable basis. For the reasons explained below, Ms.
Mazzone has established a reasonable basis for her claim. Thus, she is eligible for a reasonable
award of attorneys’ fees and costs. For Ms. Mazzone, a reasonable amount of attorneys’ fees
and costs is $74,789.83.
1
Because this decision contains a reasoned explanation for the action taken in this case, it
must be made publicly accessible and will be posted on the United States Court of Federal
Claims’ website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in
accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal
Management and Promotion of Electronic Government Services). This means the decision will
be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), the
parties have 14 days to identify and move to redact medical or other information, the disclosure
of which would constitute an unwarranted invasion of privacy. Any changes will appear in the
document posted on the website.
I. Events in Ms. Mazzone’s Medical History 2
Ms. Mazzone was born in 1960. Exhibit 5 at 541. She alleges she did not have any
history of neurologic disease before the allegedly causal vaccination. Pet., filed Dec. 12, 2022,
¶ 7. The Secretary, likewise, did not assert that any medical problem before the vaccination that
may have contributed to Ms. Mazzone developing GBS, which occurred after her vaccination.
See Resp’t’s Rep’t, filed Dec. 7, 2023, at 6-9.
Although Ms. Mazzone technically alleged as an alternative cause of action, that the flu
vaccine significantly aggravated an underlying neurologic problem, this pleading lacks any
factual support. Thus, this decision does not further discuss a cause of action based upon
significant aggravation.
Relevant medical history begins in November 2021, when she had developed renal
calculi. She was hospitalized at Kaiser for treatment of these renal calculi. During the
hospitalization on November 27, 2021, she tested negative for COVID-19. Exhibit 5 at 406. She
received the allegedly causal flu vaccine on November 30, 2021. Exhibit 5 at 424. She left the
hospital that day. Id. at 365.
On December 3, 2021, Ms. Mazzone called her primary care physician, Nisha Jadhaw,
and reported “having symptoms of congestion, rhinitis, headache, low grade temp, chills, [and a
scratchy] throat.” Exhibit 1 at 735. Dr. Jadhaw suspected her symptoms had a “likely viral
etiology.” Id.
On December 26, 2021, Ms. Mazzone began to develop fever, fatigue, shortness of
breath, cough, nausea, and vomiting. Using an at-home test, Ms. Mazzone was positive for
COVID-19. Exhibit 5 at 541, 546, 578. Ms. Mazzone had not been vaccinated for COVID-19.
Id.
Ms. Mazzone’s infection with COVID-19 worsened. On January 5, 2022, Ms. Mazzone
went to a hospital’s emergency department, reporting she “became increasingly weak over the
past 24 hours, fell last night while trying to go to bathroom, and [was] barely able to stand up.”
Exhibit 5 at 572. Her oxygen saturation in triage was 85% (normal: 95%-100%). Id. at 546.
Ms. Mazzone was diagnosed with “sepsis with acute respiratory failure secondary to COVID
pneumonia.” Id. at 578. She was treated with oxygen, bronchodilators, corticosteroids, anti-
viral medication, and a blood thinner. Id. at 579. Her blood culture was positive for gram
positive cocci bacteria, in clusters, and she was treated with IV antibiotics. Id. at 591-592, 594.
Ms. Mazzone was hospitalized for seven days and discharged on January 12, 2022, in stable
condition. Id. at 579-81. At discharge, she was prescribed an oxygen concentrator for home use
and additional corticosteroids. Id.
On January 17, 2022, forty-eight days after the flu vaccination, Ms. Mazzone was taken
to the Kaiser emergency department (“ED”) via ambulance for “[right] back pain and chest pain
that began th[at] evening.” Exhibit 5 at 496. Ms. Mazzone reported “she was doing fine
2
The relevant parts of Ms. Mazzone’s medical history are relatively few. Thus, this
decision sets them out in abbreviated fashion. However, all medical records have been
considered.
2
otherwise since being discharged” from her hospitalization for COVID-19. Id. On exam, Ms.
Mazzone had a fever and tenderness of her chest wall. Id. at 497. She had no focal weakness or
paresthesias. Id. at 498. Her white blood cell (“WBC”) count was abnormal. Id. at 499. Ms.
Mazzone was treated with oxygen and pain medications and discharged home the next day in
stable condition. Id. at 500-01.
On January 25, 2022, fifty-six days after vaccination, Ms. Mazzone was taken by
ambulance to the Kaiser ED for back pain, nausea, and vomiting. Exhibit 5 at 899-904. She
reported having vomited three times since the prior night. Exhibit 6 at 6. In the ED, the physical
exam was unremarkable. Exhibit 5 at 901. She was admitted to the hospital.
In the hospital, she underwent various tests. A nasal swab test collected the morning of
January 26, 2022, was positive for COVID-19, and negative for flu and RSV. Id. at 936, 974.
Later on January 26, 2022, Ms. Mazzone reported numbness and tingling in her hands
and ankles. Exhibit 5 at 911. She also reported that she had been “[a]ble to walk around [her]
house w[ith out] problem until two days ago when she developed paresthesia, tingling in her feet
and then leg weakness.” Id. at 981. Upon an examination, the doctor determined that she had
minimal to no deep tendon reflexes in her upper extremities as well as bilateral weakness in both
upper and lower extremities. The doctor ordered additional tests as well as a consultation with a
neurologist.
A lumbar puncture was performed on January 26, 2022. The results showed elevated
protein, albumin, and glucose levels. Exhibit 5 at 1117.
Neurologist John Neely, M.D.’s assessment was that Ms. Mazzone had “post-COVID
[GBS], presenting with low back pain on 1/25 and weakness in her limbs, worse initially in her
lower limbs, and numbness in her legs and hands beginning on 1/26,” and ordered IVIG. Id. at
988.
Infectious disease specialist Zaina El-Isa, M.D., examined Ms. Mazzone and noted:
61 y[ea]r old female presented w[ith] neurological symptoms,
COVID 1 month ago, presented with paresthesia and weakness
started in lower limbs and associated with shortness of breath but
no hypoxia. [Computed tomography angiography of the] chest
negative for [pulmonary embolism]. Areflexia on physical exam,
GBS in differential, reported 1 to 4 weeks post Covid infection
with literature review, time lag of 1-4 weeks and may be
attributable to the “immune mechanism of molecular mimicry.”
Id. at 989.
In this litigation, the parties agree that Ms. Mazzone suffered from Guillain-Barré
syndrome. See Pet. ¶ 39; Resp’t’s Rep’t at 6. The parties, however, dispute when Ms. Mazzone
first manifested symptoms or signs of the Guillain-Barré syndrome.
Details about how GBS affected Ms. Mazzone do not inform the question of whether
reasonable basis supports her claim that the flu vaccine caused her GBS. It is sufficient to note
3
that Ms. Mazzone experienced a severe case of GBS and her recovery, unfortunately, has not
been complete. For example, she required a ventilator and a feeding tube. For additional details
about the Ms. Mazzone’s course of GBS, see Pet. ¶¶ 24-39; Resp’t’s Rep. at 4-6.
When doctors were caring for Ms. Mazzone, they sometimes commented upon the
potential cause for her GBS. On May 9, 2022, as part of a telehealth appointment, Ms.
Mazzone’s primary care doctor (Nisha Jadhaw) stated that her history included “GBS possibly
2/2 [secondary to] flu shot.” Exhibit 1 at 893. On July 20, 2023, her neurologist, Dr. Neely,
stated that Ms. Mazzone had a “history of [GBS] that occurred in 1/2022 likely triggered by
COVID.” Exhibit 11 at 553.
II. Procedural History
A. Before the Petition was Filed
Ms. Mazzone first contacted the law firm that is representing her on May 10, 2022.
Exhibit 17. 3 About two weeks later, a paralegal spent approximately three hours conducting a
“thorough review of over 900 pages of client provided medical records.” Entry for May 26,
2022. It is likely that these 900 pages are records from Kaiser. About one week later, the
attorney who represents Ms. Mazzone, Jessica Huff, spent about three hours reviewing
“voluminous medical records” as well as other tasks. Entry for May 31, 2022.
Attorney Huff spoke with Ms. Mazzone for about one hour on June 1, 2022. Ms. Huff
gave Ms. Mazzone the firm’s “initial assessment of the hurdles and set expectations about
retention and expectations for the longevity of cases within the program.” Over the few days,
Ms. Mazzone retained the law firm.
Paralegals ordered and tracked down medical records. By the end of October 2022, a
paralegal spent more than 15 hours reviewing records from Kaiser. On November 10, 2022, a
paralegal began drafting the petition. More medical records were collected. The petition was
finalized and filed on December 22, 2022. The attorney who drafted the petition was Elizabeth
Abramson.
B. Petition
Because the operative part of the Vaccine Act (42 U.S.C. § 300aa–15(e)) links
“reasonable basis” to the “claim for which the petition was brought,” a close review of the
petition is consistent with the statute. The petition’s preamble lacks specificity. In relevant part,
the preamble states that Ms. Mazzone seeks compensation “for injuries resulting from adverse
effects of a vaccination or vaccinations.” The petition mentions Ms. Mazzone was hospitalized
in early January 2022, but does not allege that she was diagnosed with or suspected of having
GBS at that time. See Pet. ¶¶ 16-17. The petition mentions Ms. Mazzone again sought hospital
treatment for back pain among other problems on January 17, 2022, but similarly does not assert
any GBS at that time. See Pet. ¶¶ 18-19. Rather, the petition alleges that Ms. Mazzone was
3
Exhibit 17 is the timesheet for the attorneys and paralegals who represented Ms.
Mazzone. Future references to dates of her attorneys’ activities are based upon information in
Exhibit 17.
4
evaluated for and diagnosed with GBS, (only) in connection with her third hospitalization at the
end of January 2022. See Pet. ¶ 21. The petition also asserts that Ms. Mazzone continues to
suffer from GBS. See Pet. ¶ 39.
The petition asserts that Ms. Mazzone’s “injury is causally related to an adverse reaction
to a vaccination.” Pet. ¶ 40. The petition did not claim that Ms. Mazzone suffered an on-Table
injury. There is no indication in any time entry that an attorney attempted to consult an expert
before filing the petition. 4
C. Completion of Entitlement Phase
The Secretary contested entitlement. Resp’t’s Rep., filed Dec. 7, 2023. The Secretary
argued that Ms. Mazzone’s petition did not set forth an on-Table GBS claim, as the onset of her
symptoms was approximately 55 days after she received the flu vaccine. Resp’t’s Rep. at 6-7.
Respondent further noted that Ms. Mazzone had not presented an expert report, and her treating
doctors attributed her GBS to her COVID-19 infection. Id. at 8-9.
To discuss the Secretary’s arguments against compensation, a status conference was held
on February 8, 2024. Ms. Mazzone’s counsel was asked whether there was a valid on-Table
claim. Ms. Huff said yes, because the onset of GBS was 48 days after vaccination. This
explanation made little sense because the Secretary has associated the flu vaccine with GBS
when the GBS develops within 3-42 days of flu vaccination. 42 C.F.R. § 100.3(a)¶ XIV.D. The
Secretary, in turn, argued that the onset was actually 55 days. Thus, even if Ms. Huff’s
interpretation of the evidence were correct, Ms. Mazzone could not prevail upon an on-Table
claim. At Ms. Huff’s request, the parties were given an opportunity to resolve the case
informally.
The parties were unable to resolve the case informally. Pet’r’s Status Rep., filed March
8, 2024. Around this time, Attorney Huff began investigating the times for which an inference
of causation is medically acceptable. See time entries for Mar. 21, 2024; Mar. 26, 2024; Apr. 03,
2024.
In the ensuing status conference, Ms. Mazzone stated that she planned to obtain a report
from an expert. When asked whether the petitioner’s expert would address the COVID-19
infection as a potential alternative cause, Ms. Huff said yes, because the COVID-19 infection is
the elephant in the room. To guide the preparation of reports from experts, a set of expert
instructions was issued in draft form, and the parties were allowed to comment. The parties did
not raise any objections or concerns. Order, issued April 5, 2024. Despite this guidance, Ms.
Mazzone did not submit a report from an expert. She sought dismissal of her case voluntarily.
4
Because Ms. Mazzone received the allegedly causal flu vaccine on November 30, 2021,
the three-year statute of limitations was not close to expiring. See 42 U.S.C. § 300aa–16.
5
Pet’r’s Mot., filed July 1, 2024. Ms. Mazzone did not receive compensation. 2024 WL
3825581.
D. Attorneys’ Fees and Costs
After judgment entered, Ms. Mazzone was directed to present arguments regarding
reasonable basis in conjunction with any request for attorneys’ fees and costs. Order, issued
Aug. 26, 2024. Despite this instruction, Ms. Mazzone’s initial motion did not present any
argument as to why the claim in her petition was supported by reasonable basis. Thus, the
motion was struck. Order, issued Nov. 20, 2024.
Ms. Mazzone requests an award of attorneys’ fees and costs via the pending motion,
which was filed on December 11, 2024 (“Pet’r’s Mot.”). She requests $73,356.00 in attorneys’
fees and $3,433.83 in attorneys’ costs. Id. at 12. Ms. Mazzone generally argues that reasonable
basis supports her claim. She goes so far as to assert that “Petitioner would argue that she had
reasonable basis to pursue either an on-table or an off-table claim.” Pet’r’s Mot. at 8.
With respect to onset, Ms. Mazzone asserted that the onset of her Guillain-Barré
syndrome was 36 days after vaccination, when she became increasingly weak and fell. Pet’r’s
Mot., citing Exhibit 5 at 546-50. Thus, according to this argument, Ms. Mazzone had a valid
claim for an on-Table injury, (even though the petition did not assert it). Ms. Mazzone
alternatively argued that onset was either January 17, 2022, or January 24, 2022, which are 48
days and 55 days after vaccination respectively. She cites cases to further contend that an
interval of up to 55 days is medically appropriate to infer causation. With respect to alternative
causation, Ms. Mazzone argued that because the Secretary bears the burden of proving
alternative causation, the Secretary’s “alternative cause argument has no bearing on whether
Petitioner had a reasonable basis to file her petition.” Id. at 11.
The Secretary opposed any award of attorneys’ fees and costs. The Secretary argued for
a complete denial of fees:
Petitioner lacks a reasonable basis for her claim. The objective
evidence indicates that petitioner neither began her case with a
reasonable basis, nor did one emerge as her case progressed. For
the reasons explained below, petitioner’s record evidence does not
rise to more than a scintilla of evidence in support of her claim.
Her Fee Motion must be denied.
Resp’t’s Resp., filed Jan. 8, 2025, at 12. The Secretary reviewed each of the three elements
required to establish causation-in-fact, see Althen v. Sec’y of Health & Hum. Servs., 418 F.3d
1274, 1278 (Fed. Cir. 2005), and argued that Ms. Mazzone did not submit a scintilla of evidence
on any prong. The Secretary also maintained that Ms. Mazzone’s “failure to recognize COVID-
19 as the likely cause of her GBS before reviewing respondent’s Rule 4(c) Report does not
confer reasonable basis to her claim.” Id. at 16. 5
5
In accord with the Secretary’s practice, the Secretary did not interpose any objection to
the amount of attorneys’ fees and costs requested.
6
Ms. Mazzone defended her request for attorneys’ fees and costs. She argued that any of
the three proposed onset dates were medically acceptable. Pet’r’s Reply, filed Jan. 21, 2025, at
2. With respect to the Secretary’s argument that she did not present a medical theory, Ms.
Mazzone argued that the Secretary’s “entire argument here does not take the timing of this case
into account.” Id. at 3. She also continued to dispute whether she was required to address
alternative causation as part of reasonable basis. Id. at 3-4. Ms. Mazzone also cited Dr.
Jadhaw’s note that Ms. Mazzone’s “GBS possibly 2/2 [secondary to] flu shot.” Id. at 4, citing
Exhibit 1 at 893. Ms. Mazzone maintains that she could not have known, “prior to consulting
with an expert, that she could not prevail in this case. However, this attributes expertise in the
area of neurology onto Petitioner and counsel, something that is not required under this
program.” Id. at 3.
With the submission of the reply, the case is ready for adjudication. The analysis is
contained in two separate parts. The first part addresses whether Ms. Mazzone should receive
any attorneys’ fees and costs. Because the answer to that analysis is yes, the second part
analyzes the amount of attorneys’ fees and costs that is reasonable.
III. Analysis Part One: Eligibility for Attorneys’ Fees and Costs
The first part of the analysis is to determine whether Ms. Mazzone should receive any
attorneys’ fees and costs. This analysis is contained in three sections. Section A sets forth the
standards for determining whether reasonable basis supports the claims in a petition. Section B
considers whether Ms. Mazzone met her burden to show reasonable basis. Finally, Section C
resolves whether Ms. Mazzone should be awarded her reasonable attorneys’ fees and costs as a
matter of discretion.
A. Standards for Adjudication regarding Reasonable Basis
To be entitled to compensation, petitioners must establish five elements, which are found
in 42 U.S.C. § 300aa–11(c)(1)(A)-(E). When petitioners establish all five elements with
preponderant evidence (and respondent does not establish an alternative factor explaining the
medical disorder), petitioners are entitled to receive compensation. 42 U.S.C. § 300aa–13. One
type of compensation successful petitioners receive is an award of reasonable attorneys’ fees and
costs. 42 U.S.C. § 300aa–15(e).
By way of contrast, petitioners who did not establish entitlement are not awarded
attorneys’ fees and costs automatically. The Vaccine Act grants special masters discretion to
award attorneys’ fees and costs upon a showing of two items: “that the petition was brought in
good faith and there was a reasonable basis for the claim for which the petition was brought.” 42
U.S.C. § 300aa–15(e). 6 As the fee applicant, Ms. Mazzone bears the burden of demonstrating
reasonable basis. McKellar v. Sec’y of Health & Hum. Servs., 101 Fed. Cl. 297, 305 (2011).
It is well established that the standard of establishing reasonable basis is lower than a
preponderance of the evidence. The Federal Circuit stated: “more than a mere scintilla but less
than a preponderance of proof could provide sufficient grounds for a special master to find
6
Here, as in most cases, the Secretary has not argued that Ms. Mazzone lacked good
faith.
7
reasonable basis.” Cottingham v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1346 (Fed.
Cir. 2020). However, the Federal Circuit did not define a “scintilla.” Petitioners meet their
evidentiary burden with “objective evidence.” Id. at 1344. In categorizing medical records as
objective evidence, the Federal Circuit stated, “[m]edical records can support causation even
where the records provide only circumstantial evidence of causation.” Id. at 1346. Finally, the
Federal Circuit in Cottingham specified that “we make no determination on the weight of the
objective evidence in the record or whether that evidence establishes reasonable basis, for these
are factual findings for the Special Master and not this court.” Id. at 1347.
As to what must potentially be shown with a scintilla of evidence, the Federal Circuit has
offered some guidance. The same five elements necessary to establish causation can be
considered in determining whether a petition was supported by a reasonable basis. Cottingham,
971 F.3d at 1345-46. 7 In Cottingham, the disputed item concerned causation, which is
subparagraph C in section 11(c)(1) of the Vaccine Act.
Furthermore, according to the Court of Federal Claims, the finding of a scintilla does not
mandate a finding of reasonable basis. Cottingham v. Sec’y of Health & Hum. Servs., 159 Fed.
Cl. 328, 336 (2022) (denying motion for review of decision not to award attorneys’ fees and
costs), aff’d without op., 2023 WL 7545047 (Fed. Cir. 2023).
In a precedential opinion regarding the reasonable basis standard, the Federal Circuit
stated that medical records, affidavits, and sworn testimony all constitute objective evidence that
could support reasonable basis. James-Cornelius v. Sec’y of Health & Hum. Servs., 984 F.3d
1374, 1379-81 (Fed. Cir. 2021). The Federal Circuit further clarified that “absence of an express
medical opinion on causation is not necessarily dispositive of whether a claim has reasonable
basis, especially when the case is in its early stages and counsel may not have had the
opportunity to retain qualified experts.” Id. at 1379 (citing Cottingham, 971 F.3d at 1346).
More recently, the Federal Circuit held that in assessing whether reasonable basis
supports the claims set forth in a petition, a special master may structure the analysis around the
Althen prongs. Sheller v. Sec’y of Health & Hum. Servs., 121 F.4th 1301, 1305-07 (Fed. Cir.
2024). In doing so, the special master should recognize that the quantum of evidence for
reasonable basis is lower than the quantum of evidence for entitlement. Id. In doing so, the
Federal Circuit “caution[ed] against a rigid application of the Althen factors because a rigid
application, which requires some quantum of evidence for each Althen factor, could exceed what
is required to establish a ‘reasonable basis.’” Id. 8
7
Ms. Mazzone argued that: “Petitioner met all the requirements for reasonable basis
including having received a covered vaccine, an onset within a medically acceptable amount of
time, and sequelae lasting longer than six months.” Pet’r’s Reply at 3. This list of required
elements is accurate but incomplete.
8
By way of contrast, petitioners must fulfill all three Althen prongs to receive
compensation. W.C. v. Sec’y of Health & Hum. Servs., 704 F.3d 1352, 1358 (Fed. Cir. 2013)
(“a petitioner must establish all three prongs of the Althen test”).
8
Although the reasonable basis standard does not set an especially high bar, evaluations of
reasonable basis must contain sufficient detail to allow an appellate court to review the
reasoning. Stratton v. Sec'y of Health and Hum. Servs., 138 F.4th 1368, 1378 (Fed. Cir. 2025).
B. Evaluation of Reasonable Basis
With respect to the five statutory elements found in 42 U.S.C. § 300aa–11(c)(1), Ms.
Mazzone easily satisfies four of them. These uncontested elements are (A) receiving a vaccine
listed in the Vaccine Injury Table, (B) receiving the vaccine in the United States, (D) suffering
the consequence of the injury for more than six months, and (E) not previously collecting
compensation. Thus, the only disputed item is causation, which is in paragraph (C). A
deficiency of proof on causation can justify a finding that a petitioner lacked reasonable basis.
See Cottingham, 971 F.3d at 1346 (stating “[b]ecause “causation is a necessary element of a
petition,” a petitioner “must point to evidence of a causal relationship” to establish reasonable
basis” and remanding); Cottingham, 159 Fed. Cl. at 328 (denying a motion for review of
decision finding a lack of reasonable basis due to insufficient evidence regarding causation);
Chuisano v. United States, 116 Fed. Cl. 276, 288–89 (Fed. Cl. 2014) (“reasonableness may []
come into question if . . . the lack of supporting evidence becomes apparent.”).
As to how Ms. Mazzone planned to meet her burden of proof with respect to paragraph
C / causation, her petition is not a model of clarity. The general impression is that the petition
did not present an on-Table claim. In this regard, the lack of an explicit assertion regarding an
on-Table claim appears telling. Furthermore, the petition did not assert that Ms. Mazzone
developed GBS within the time recognized on the Table. Nevertheless, in an attempt to support
her request for an award of attorneys’ fees and costs, Ms. Mazzone states that “Petitioner would
argue that she had reasonable basis to pursue either an on-table or an off-table claim.” Pet’r’s
Mot. at 8. Because the elements of proof regarding causation differ for an on-Table claim and an
off-Table claim, the analysis is taken up in two different sections.
1. On-Table Claim
A petitioner establishes a presumption of causation by showing that she
sustained . . . any illness . . . set forth in the Vaccine Injury Table
in association with [a] vaccine ... and the first symptom or
manifestation of the onset . . . any such illness . . . occurred within
the time period after vaccine administration set forth in the
Vaccine Injury Table.
42 U.S.C. § 300aa-11(c)(1)(C)(i). Here, the evidence shows that Ms. Mazzone received a flu
vaccine and developed GBS. The Vaccine Injury Table, in turn, associates the flu vaccine with
GBS when “the first symptom or manifestation of the onset” of the GBS occurs within 3-42
days. 42 C.F.R§ 100.3(a)¶ XIV.D.
The question becomes whether there was a reasonable basis for asserting that Ms.
Mazzone’s GBS developed within 3-42 days. The answer is no. There is not a reasonable basis
for asserting that Ms. Mazzone’s GBS developed within 3-42 days.
9
As a preliminary matter, it bears discussing that Ms. Mazzone’s petition appears not to
assert a claim based upon the Table. Most notably, it contains no explicit allegation that Ms.
Mazzone suffered a Table injury. In fact, the word “Table” does not appear within the petition at
all. Nor does the petition implicitly present an on-Table claim by alleging that Ms. Mazzone
developed GBS within the 3-42 day Table, as discussed more below. Further, there was no
request for referral to the Special Processing Unit of the Office of Special Masters. 9 The
Secretary, too, did not view the petition as asserting an on-Table claim. See Resp’t’s Rep. at 6
(“petitioner does not allege a Table GBS injury”). Thus, it is highly doubtful that Ms.
Mazzone’s petition “sets forth” the claim of an on-Table injury. See 42 U.S.C. § 300aa-15(e). If
the petition did not set forth the claim of an on-Table injury, then the analysis could end.
Nevertheless, to demonstrate all of Ms. Mazzone’s evidence and arguments have been
considered, this section will assume for sake of argument that the petition does (implicitly) assert
an on-Table claim.
Asserting a claim is not the equivalent of establishing a reasonable basis for the claim.
Otherwise, the reasonable basis standard, which Congress placed in section 15(e) of the Vaccine
Act, would be meaningless. After the Federal Circuit’s opinion in Simmons, it is clear that
reasonable basis is an “objective” test, meaning one evaluated based upon evidence. See
Harville v. Sec'y of Health and Hum. Servs., No. 21-1893, 2025 WL 1806434, at *6-7 (June 5,
2025) (finding no reasonable basis for an on-Table claim).
In determining whether to award compensation, special masters are expected to base
opinions upon medical records or medical opinion. 42 U.S.C. § 300aa-13(a). In the context of
determining whether a petitioner is entitled to compensation, when a petitioner claims to have
suffered a Table injury, a petitioner must establish with preponderant evidence that the vaccinee
suffered the injury using medical records or the statement from an expert. See Harrington v.
Sec'y of Health and Hum. Servs., 139 Fed. Cl. 465, 469 (2018) (denying motion for review and
ruling that the special masters correctly concluded that petitioner failed to establish that he
suffered from GBS); Keith v. Sec'y of Health and Hum. Servs., 55 Fed. Cl. 791, 797 (2003).
Although both Harrington and Keith were decided in the context of a claim for entitlement, the
basic analysis guides an assessment of reasonable basis, which requires a lower level of proof.
The difference between entitlement to compensation and eligibility for attorneys’ fees concerns
the burden of proof, not the methods of proof. See Cottingham, 971 F.3d at 1346.
On the topic of whether Ms. Mazzone developed GBS within 3-42 days of her flu
vaccination, there is a dearth of evidence. For the category of “medical opinion,” Ms. Mazzone
never submitted the report of any expert, presenting any opinion. Thus, the evidence, if it is to
be found, would be contained in the “medical records.” 10
Ms. Mazzone has not cited any medical records that support her assertion that she
developed GBS within 3-42 days of the vaccination. Ms. Mazzone contended: “Petitioner
9
Although the case was assigned to the special processing unit, Ms. Mazzone has not
argued that this action contributes to her arguments regarding reasonable basis.
10
Special masters also should consider affidavits when the affiant is competent to testify
about the matters contained in the affidavit. James-Cornelius, 984 F.3d at 1379-81.
10
argued that onset occurred at 36 post-vaccination, on January 5, 2022, when Petitioner became
increasingly weak and fell ill. Ex. 5 at 546-50.” Pet’r’s Mot. at 7. Later, Ms. Mazzone similarly
stated: “Petitioner has maintained that the medical records support a finding of onset within 36
days of vaccination. Ex. 5 at 546-50.” Id. at 8. 11 Thus, according to way Ms. Mazzone has
argued her motion for attorneys’ fees, any basis for the claim that she suffered GBS on January
5, 2022, will be found within pages 546-50 of Exhibit 5.
The medical record found on those pages reflects Ms. Mazzone’s appearance at an
emergency room on January 5, 2022. The chief complaint includes “shortness of breath” in the
context of testing positive at home for COVID-19. Exhibit 5 at 546. In the review of systems,
Ms. Mazzone was negative for, among other conditions, “numbness.” Id. at 547. As part of the
neurologic examination, the doctor determined that Ms. Mazzone had “No sensory deficit,” and
“No weakness.” Id. at 548. Likewise, her coordination and gait were “normal.” Id. After
receiving laboratory studies, Ms. Mazzone was discharged home. There were three diagnoses
listed: “1. Coronavirus Covid-19 disease” “2. Shortness of Breath,” and “3. Fever.” Id. at 550.
Ms. Mazzone has not explained how this presentation is consistent with a diagnosis of
GBS. To start with the bottom line, the doctor who treated her in the emergency room did not
diagnose GBS and, instead, discharged her home. Exhibit 5 at 550. Ms. Mazzone cannot point
to a doctor’s statement that on January 5, 2022, she suffered from GBS. Moreover, in the
undersigned’s experience, the lack of numbness, the lack of sensory deficits, the lack of
weakness, the normal coordination, and the normal gait make the diagnosis of GBS unlikely.
Similarly, the doctor’s determination that Ms. Mazzone could be discharged from the emergency
room seems inconsistent with GBS, which often declines abruptly.
In short, there is so little evidence supporting the contention that Ms. Mazzone
experienced GBS on January 5, 2022, that Ms. Mazzone’s argument to gain her eligibility for
attorneys’ fees appears not grounded in good faith. Therefore, the arguing attorney’s credibility
is reduced.
2. Off-Table Claim
As an alternative to an on-Table claim, a petitioner can pursue an off-Table claim. 42
U.S.C. § 300aa-11(c)(1)(C)(ii)(I); Moberly v. Sec'y of Health and Hum. Servs., 592 F.3d 1315,
1321 (Fed. Cir. 2010). Off-Table claims are also known as “causation-in-fact” claims. The most
natural reading of Ms. Mazzone’s petition is that she was alleging that the flu vaccine was the
cause-in-fact of her GBS.
Petitioners establish causation-in-fact by meeting the three prongs set out in Althen v.
Sec'y of Health and Hum. Servs., 418 F.3d 1274 (Fed. Cir. 2005). These are: “(1) a medical
theory causally connecting the vaccination and the injury; (2) a logical sequence of cause and
effect showing that the vaccination was the reason for the injury; and (3) a showing of a
11
On both pages 7 and 8, Ms. Mazzone used a verb’s past tense: she “argued” and she
“maintained” the onset of her GBS as 36 days after vaccination. However, it is not clear when
before her pending motion seeking attorneys’ fees that she contended that the onset was 36 days
after vaccination.
11
proximate temporal relationship between vaccination and injury.” Id. at 1278. In considering
whether a petitioner has shown that a reasonable basis supports the claims set forth in a petition,
special masters may structure the analysis around the Althen prongs. However, the Federal
Circuit has “caution[ed] against a rigid application of the Althen factors because a rigid
application, which requires some quantum for each Althen factor, could exceed what is required
to establish ‘reasonable basis.’” Sheller, 121 F.4th at 1307. The level of proof for reasonable
basis remains lower than the proof required for entitlement.
Here, Ms. Mazzone argues that reasonable basis supports her claim based upon two
points. The first point is based upon rulings in other cases. The second point is based upon a
statement from a treating doctor.
Rulings in Other Cases. Based upon Sheller, Ms. Mazzone seems to argue that once
special masters accept a specific combination of vaccine and injury, other future petitioners are
not required to submit evidence regarding how a vaccine can cause an injury. See Pet’r’s Br. at
9. Along this line, Ms. Mazzone cites three cases in which a special master credited the opinion
of a doctor retained by the petitioner regarding the appropriate interval. These three cases are:
Pierson v. Sec'y of Health & Hum. Servs., No. 17-1136V, 2022 WL 322836, at *32 (Fed. Cl.
Spec. Mstr. Jan. 19, 2022); Spayde v. Sec'y of Health & Hum. Servs., No. 16-1499V, 2021 WL
686682, at *18 (Fed. Cl. Spec. Mstr. Jan. 27, 2021); Barone v. Sec'y of Health & Hum. Servs.,
No. 11-707V, 2014 WL 6834557, at *13 (Fed. Cl. Spec. Mstr. Nov. 12, 2014). 12 They can be
summarized:
Name Vaccine Injury Pet’r’s Expert Theory Latency Comments
Barone Flu GBS Dr. Tornatore Molecular 6 weeks Respondent did not
mimicry present an expert.
Spayde Flu GBS Dr. Forsyth Molecular 49-60 Respondent’s expert
(treater) & Dr. mimicry days was contradictory on
Alkaitis onset.
Pierson Prevnar GBS Dr. Steinman Molecular Within Dr. Steinman relied
mimicry 56 days upon Schoenberger
Before the Federal Circuit’s opinion in Sheller, the Federal Circuit had stated that special
masters should look to “objective” evidence supporting a petitioner’s claim. Simmons v. Sec’y
of Health & Hum. Servs., 875 F.3d 632, 636 (Fed. Cir. 2017). Sheller found that petitioner’s
failure to offer evidence in the form of an expert’s report was excusable because of unusual
circumstances in which the expert’s causal theory was being reviewed by appellate authorities
12
Ms. Mazzone cites a fourth case, Osorio v. Sec'y of Health & Hum. Servs., No. 18-
1835V, 2021 WL 3370218, at *7 (Fed. Cl. Spec. Mstr. July 9, 2021), but in Osorio the special
master did not find entitlement.
12
when Mr. Sheller was developing his claim. Sheller, 121 F.4th at 1308. Whether Sheller should
be limited to situations with similar unusual circumstances is not clear.
Determining how broadly or how narrowly Sheller should be interpreted is not necessary
to resolve Ms. Mazzone’s pending motion for attorneys’ fees and costs. As mentioned
previously, Ms. Mazzone’s argument regarding reasonable basis rests upon more than similar
cases.
Treating Doctor. In the entitlement context, a statement from a treating doctor merits
careful consideration. Capizzano v. Sec’y of Health & Hum. Servs., 440 F.3d 1317, 1327 (Fed.
Cir. 2006). So, too, in determining whether reasonable basis supports the claim set forth in a
petition, a special master should weigh a statement from a treating doctor.
To shore up the petition’s claim that the flu vaccine caused her GBS, Ms. Mazzone relies
upon a medical record from Dr. Jadhaw who conducted a telehealth visit with Ms. Mazzone on
May 9, 2022. Pet’r’s Mot. at 11; see also Pet’r’s Reply at 4 (citing same record). Dr. Jadhaw’s
“History of